long-term effects of glp-1 drugs Medications Infographic Long-Term Effects Of GLP-1 Medications:

Wong, M

Tirzepatide is approved as Mounjaro for T2D and as Zepbound for chronic weight management and, notably by the FDA, for treatment of moderate to severe OSA in adults with obesity

The list of FDA-approved indications for this class of medication has grown as of late (and currently includes type 2 diabetes, obesity, cardiovascular event risk reduction, obstructive sleep apnea, chronic kidney disease, and metabolic dysfunction-associated steatotic liver disease), and areas of interest for potential future indications are just as long and farreaching

The category has also gained global attention for its weight-loss benefits

doi: 10.1111/jnc.15521 24 RodeAKOBuusTBMrazVAl-JaberiFAHLopezDVFordSLet al